Development and validation of a clinical-radiomics nomogram for differentiating Mycoplasma pneumoniae pneumonia from bacterial pneumonia in children - Scorecard - MDSpire
Advertisement
Development and validation of a clinical-radiomics nomogram for differentiating Mycoplasma pneumoniae pneumonia from bacterial pneumonia in children
Clinical Scorecard: Creation and assessment of a clinical-radiomics nomogram to distinguish Mycoplasma pneumoniae pneumonia from bacterial pneumonia in pediatric patients
At a Glance
Category
Detail
Condition
Mycoplasma pneumoniae pneumonia vs. bacterial pneumonia
Key Mechanisms
Integration of clinical indicators, CT imaging findings, and radiomics features
Target Population
Pediatric patients with pneumonia
Care Setting
Clinical decision-support tool for pneumonia diagnosis
Key Highlights
Developed a nomogram to differentiate MPP from BP in children
Utilized clinical and CT imaging data from 585 pediatric pneumonia patients
Achieved AUC of 0.971 for the combined nomogram model
Incorporated machine learning techniques for model construction
Demonstrated significant net clinical benefit through decision curve analysis
Guideline-Based Recommendations
Diagnosis
Use microbial culture as the gold standard for pathogen identification
Consider nucleic acid amplification testing for high sensitivity
Management
Targeted antimicrobial therapy based on accurate pathogen identification
Monitoring & Follow-up
Evaluate model performance using ROC curves and calibration curves
Risks
Manual image interpretation is subjective and dependent on clinician expertise
Patient & Prescribing Data
Pediatric patients diagnosed with single-pathogen MPP or BP
Early clinical differentiation can guide targeted therapy
Clinical Best Practices
Utilize CT imaging in acute evaluation of pneumonia
Incorporate radiomics for enhanced diagnostic accuracy
